Hyperfiltration, nitric oxide, and diabetic nephropathy

Area of Science:

• Nephrology
• Endocrinology
• Physiology

Background:

• Early diabetes mellitus is associated with increased glomerular filtration rate (GFR), a phenomenon known as hyperfiltration.
• Hyperfiltration is significantly influenced by elevated nitric oxide activity and is implicated in the progression of diabetic nephropathy.
• Altered tubuloglomerular feedback (TGF) mechanisms in diabetes contribute to hyperfiltration and subsequent kidney damage.

Purpose of the Study:

• To review techniques for in vivo, real-time measurement of tubular fluid nitric oxide.
• To describe findings related to nitric oxide and hyperfiltration in rodent models of diabetes.
• To investigate the modulation of hyperfiltration and TGF in type 2 diabetes using a nitric oxide synthase inhibitor.

Main Methods:

• Review of in vivo, real-time measurement techniques for tubular fluid nitric oxide.
• Analysis of data from three common rodent models of diabetes.
• Experimental modulation of the TGF mechanism and single-nephron GFR in db/db mice using a nitric oxide synthase inhibitor.

Main Results:

• The study reviews methods for measuring tubular fluid nitric oxide in real-time.
• Findings in rodent models highlight the role of nitric oxide in diabetes-associated hyperfiltration.
• In db/db mice, a nitric oxide synthase inhibitor suppressed the TGF mechanism and modulated single-nephron GFR.

Conclusions:

• Nitric oxide plays a crucial role in diabetes-induced hyperfiltration and the progression of diabetic nephropathy.
• The tubuloglomerular feedback mechanism is altered in diabetes, contributing to hyperfiltration.
• Targeting nitric oxide synthase offers a potential strategy for modulating hyperfiltration in type 2 diabetes.